Shirley X.Y. WuProfile page
Professor
Leslie Dan Faculty of Pharmacy
BIO
Dr. Xiao Yu (Shirley) Wu is a Professor under the Leslie Dan Faculty of Pharmacy at the University of Toronto and an elected Fellow of the American Association of Pharmaceutical Scientists (AAPS). Dr. Wu's educational background is grounded in polymer science and engineering to aid her in developing new forms of drug delivery. She received her PhD at McMaster University for Chemical Engineering with a thesis on polyelectrolytes and stimulus-responsive nanohydrogels. Dr. Wu joined the University of Toronto in 1994 as a tenure-tracked faculty member and achieved full professorship in 2006.
During Dr. Wu's 23-year academic career, she has overseen a well-funded, cutting-edge research programme and established herself as an international authority and leader in the fields of controlled release dosage forms and cutting-edge drug delivery systems. She is a committed educator who has spent the past 20 years teaching pharmaceutics and drug delivery to faculty members at both the graduate and undergraduate levels. She has trained more than 150 graduate students, undergraduate research students, and postdoctoral researchers working in her lab in pharmaceutics, drug delivery, and drug development.
The focus of research at Dr. Wu's Advanced Pharmaceutics and Drug Delivery Laboratory is on cutting-edge pharmaceutics and medication delivery techniques for unmet medical needs. Blood-brain barrier-penetrating nanoparticles for the treatment and diagnosis of brain cancer and CNS diseases are one of our ongoing projects. Others include synergistic drug combination nanomedicine for improving chemotherapy, bioreactive hybrid metal oxide nanoparticles for altering the tumour microenvironment and improving cancer therapies, rational and computer-aided design of controlled release dosage forms, and stimulus-responsive systems for closed-loop delivery of therapeutic hormones for diabetes.
She works closely with academic and professional scientists in the pharmaceutical sector. Dr. Wu has given more than 100 invited presentations, published more than 150 journal articles and book chapters, and contributed to more than 270 conference proceedings and abstracts. She is a co-inventor of 25 issued or ongoing patents in the globe.
Media availability: TV, Radio, Print/Online
During Dr. Wu's 23-year academic career, she has overseen a well-funded, cutting-edge research programme and established herself as an international authority and leader in the fields of controlled release dosage forms and cutting-edge drug delivery systems. She is a committed educator who has spent the past 20 years teaching pharmaceutics and drug delivery to faculty members at both the graduate and undergraduate levels. She has trained more than 150 graduate students, undergraduate research students, and postdoctoral researchers working in her lab in pharmaceutics, drug delivery, and drug development.
The focus of research at Dr. Wu's Advanced Pharmaceutics and Drug Delivery Laboratory is on cutting-edge pharmaceutics and medication delivery techniques for unmet medical needs. Blood-brain barrier-penetrating nanoparticles for the treatment and diagnosis of brain cancer and CNS diseases are one of our ongoing projects. Others include synergistic drug combination nanomedicine for improving chemotherapy, bioreactive hybrid metal oxide nanoparticles for altering the tumour microenvironment and improving cancer therapies, rational and computer-aided design of controlled release dosage forms, and stimulus-responsive systems for closed-loop delivery of therapeutic hormones for diabetes.
She works closely with academic and professional scientists in the pharmaceutical sector. Dr. Wu has given more than 100 invited presentations, published more than 150 journal articles and book chapters, and contributed to more than 270 conference proceedings and abstracts. She is a co-inventor of 25 issued or ongoing patents in the globe.
Media availability: TV, Radio, Print/Online
DEGREES
- PhD, Chemical EngineeringMcMaster University, Hamilton, Canada1987 - 1992
LANGUAGES
- EnglishCan read, write, speak, understand and peer review
AVAILABILITY
- Media enquiries
INSTITUTIONAL STRATEGIC INITIATIVES
- PRiME (Precision Medicine Initiative)